<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1383520</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Exploring diabesity pathophysiology through proteomic analysis using <italic>Caenorhabditis elegans</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Subhadra</surname>
<given-names>Malaimegu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2833494"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mir</surname>
<given-names>Dilawar Ahmad</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/630318"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ankita</surname>
<given-names>Koley</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sindunathy</surname>
<given-names>Muthukrishnan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kishore</surname>
<given-names>Hambram David</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2663750"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ravichandiran</surname>
<given-names>Velayutham</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Balamurugan</surname>
<given-names>Krishnaswamy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/267521"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Biotechnology, Alagappa University</institution>, <addr-line>Karaikudi, Tamil Nadu</addr-line>, <country>India</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)</institution>, <addr-line>Kolkata, West Bengal</addr-line>, <country>India</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mainak Banerjee, Institute of Post Graduate Medical Education And Research (IPGMER), India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Sudhanshu Kumar Bharti, Patna University, India</p>
<p>Junjun Liu, Shandong Academy of Medical Sciences (SDAMS), China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Krishnaswamy Balamurugan, <email xlink:href="mailto:bsuryar@yahoo.com">bsuryar@yahoo.com</email>; <email xlink:href="mailto:balamurugank@alagappauniversity.ac.in">balamurugank@alagappauniversity.ac.in</email>; Velayutham Ravichandiran, <email xlink:href="mailto:directorniperkolkata@gmail.com">directorniperkolkata@gmail.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1383520</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Subhadra, Mir, Ankita, Sindunathy, Kishore, Ravichandiran and Balamurugan</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Subhadra, Mir, Ankita, Sindunathy, Kishore, Ravichandiran and Balamurugan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Diabesity, characterized by obesity-driven Type 2 diabetes mellitus (T2DM), arises from intricate genetic and environmental interplays that induce various metabolic disorders. The systemic lipid and glucose homeostasis is controlled by an intricate cross-talk of internal glucose/insulin and fatty acid molecules to maintain a steady state of internal environment.</p>
</sec>
<sec>
<title>Methods</title>
<p>In this study, <italic>Caenorhabditis elegans</italic> were maintained to achieve glucose concentrations resembling the hyperglycemic conditions in diabetic patients to delve into the mechanistic foundations of diabesity. Various assays were conducted to measure intracellular triglyceride levels, lifespan, pharyngeal pumping rate, oxidative stress indicators, locomotor behavior, and dopamine signaling. Proteomic analysis was also performed to identify differentially regulated proteins and dysregulated KEGG pathways, and microscopy and immunofluorescence staining were employed to assess collagen production and anatomical integrity.</p>
</sec>
<sec>
<title>Results</title>
<p>Worms raised on diets high in glucose and cholesterol exhibited notably increased intracellular triglyceride levels, a decrease in both mean and maximum lifespan, and reduced pharyngeal pumping. The diabesity condition induced oxidative stress, evident from heightened ROS levels and distinct FT-IR spectroscopy patterns revealing lipid and protein alterations. Furthermore, impaired dopamine signaling and diminished locomotors behavior in diabesity-afflicted worms correlated with reduced motility. Through proteomic analysis, differentially regulated proteins encompassing dysregulated KEGG pathways included insulin signaling, Alzheimer&#x2019;s disease, and nicotinic acetylcholine receptor signaling pathways were observed. Moreover, diabesity led to decreased collagen production, resulting in anatomical disruptions validated through microscopy and immunofluorescence staining.</p>
</sec> <sec>
<title>Discussion</title>
<p>This underscores the impact of diabesity on cellular components and structural integrity in <italic>C. elegans</italic>, providing insights into diabesity-associated mechanisms.</p>
</sec>

</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<graphic xlink:href="fendo-15-1383520-g008.tif" position="anchor"/>
</p>
</abstract>
<kwd-group>
<kwd>
<italic>C. elegans</italic>
</kwd>
<kwd>diabesity</kwd>
<kwd>triglyceride</kwd>
<kwd>lipids</kwd>
<kwd>ATGL-1</kwd>
<kwd>proteomics</kwd>
<kwd>immunofluorescence</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="101"/>
<page-count count="16"/>
<word-count count="7119"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Diabetes: Molecular Mechanisms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Over the past few decades, there has been a steady rise in the prevalence of overweight and obesity worldwide. Obesity and overweight are significant risk factors for many chronic conditions, such as diabetes, heart disease, and several forms of cancer (<xref ref-type="bibr" rid="B1">1</xref>). The combined harmful health impacts of obesity and diabetes are often referred to as &#x201c;diabesity&#x201d; (<xref ref-type="bibr" rid="B2">2</xref>) to characterize the significant pathophysiological relationship between diabetes and excess body weight. The global obesity pandemic of the past few decades has resulted in an exponential increase in the prevalence of diabetes globally. Additionally, it is anticipated that this may raise the prevalence of other related chronic conditions such dyslipidemia, hypertension, obstructive sleep apnea (OSA), metabolic-associated fatty liver disease (MAFLD), decline brain health and cardiovascular disease (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). The proposed mechanism in the development of diabetes mellitus is visceral obesity, which results in insulin resistance (<xref ref-type="bibr" rid="B5">5</xref>). Another theory that has been put out is the overabundance of circulating lipid substrates, like fatty acids, brought on by a high-fat diet, which also causes oxidative stress and chronic inflammation (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). It has also been demonstrated that triglyceride build-up in the liver and skeletal muscle promotes insulin resistance by compromising insulin signaling (<xref ref-type="bibr" rid="B8">8</xref>). Studies have elucidated that the metabolic dysregulation due to obesity results in lipotoxicity, cytotoxicity, and adipocyte stress which contribute to the development of diabesity (<xref ref-type="bibr" rid="B9">9</xref>). Thus, the most effective way to treat the illness should also involve regulating obesity as much as possible (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Various studies have shown <italic>C. elegans</italic> to be one of the simplest models for studying fat metabolism and screening anti-obesity agents (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>Recent genome-wide association studies and whole-exome sequencing investigations have uncovered a significant number of genetic variations associated with overweight/obesity and/or T2DM (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Several model species have been utilized to examine the various factors that can contribute to the onset of diabesity (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>). In order to comprehend the behavioral and metabolic controls throughout the condition of diabetes, the current study used the model nematode, <italic>C. elegans</italic>. It is the first ever report of diabesity proteomics in this popular model organism. The genetically adaptable organism <italic>C. elegans</italic> has shown to be an excellent model system for novel insights into the regulation of metabolism, aging, animal development, and brain processes. The worm system offers special opportunity to learn about the physiological activities during diabesity condition (<xref ref-type="bibr" rid="B12">12</xref>) because the associations between nutrition availability and these physiological processes present several unresolved disease-related biology concerns involving insulin controls.</p>
<p>In the current study, <italic>C. elegans</italic> has been developed as a model to understand the diabesity condition which was confirmed through the estimation of cholesterol, glucose, triglycerides and lipid droplet accumulation after force feeding the high glucose and high cholesterol as diet. The modifications in underlying molecular processes that impact the phenotypes resulting from the condition of diabesity were examined. The impact of diabesity condition on physiology was observed through lifespan, pharyngeal pumping, motility and thrashing assays. Further the investigations have offered additional insights into the potential mechanisms underlying the interaction facilitated by ATGL-catalyzed lipolysis. Altogether, this study delves into ATGL&#x2019;s role in cell signaling pathways that promote fatty acid and oxidative metabolism in <italic>C. elegans</italic>, particularly in the framework of physiological abnormalities associated with diabesity. Utilizing immunostaining and sectioning techniques on worms reveals unique phenotypes in <italic>C. elegans</italic> under diabesity conditions, compared to control group. Supportively, the proteomics study through LC-MS revealed the molecular mechanisms that underlying pathophysiology of diabesity.</p>
<p>Thus, the present research in <italic>C. elegans</italic> highlighted the understanding on physiological, behavioral and metabolic regulations occurred in connection with diabesity condition. Furthermore, the model, <italic>C. elegans</italic> has continued to be a major contributor in understanding the mechanisms involved in triglyceride accumulation and role of ATGL in fatty acid metabolism through proteomics approach.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Culture conditions</title>
<p>The <italic>C. elegans</italic> N2 Bristol wild-type strain was acquired from the CGC (<italic>Caenorhabditis</italic> Genetics Centre), funded by the NIH National Center for Research Resource in Minnesota, USA. Standard methods as described by Brenner (1974) (<xref ref-type="bibr" rid="B20">20</xref>) were utilized for the cultivation and observation of <italic>C. elegans</italic>. N2 worms were cultured and maintained at 20&#xb0;C on Nematode Growth Media (NGM) plates, utilizing <italic>Escherichia coli</italic> strain OP50 as the primary food source, which served as the control in all assays and analyses. Diabesity in worms was induced by supplementing glucose (100 mM) + cholesterol (25 &#xb5;M) into nutrient-rich substrate on NGM agar plates. The survival assay was conducted following the protocol outlined by Mir et&#xa0;al. (2020) (<xref ref-type="bibr" rid="B21">21</xref>). Synchronized adult-stage organisms were obtained by treating adult-stage hermaphrodites with a mixture of commercial bleach and 5 M KOH in a 1:1 ratio (<xref ref-type="bibr" rid="B22">22</xref>).</p>
</sec>
<sec id="s2_2">
<title>Survival assay</title>
<p>Age-synchronized L4 stage worms were subsequently transferred to 24-well plates for three biological replicates containing fluorodeoxyuridine (FUDR). Survival assessments began on the first day of adulthood, with each condition represented by a population of 40 or more worms. <italic>E. coli</italic> OP50 was added to the experimental setup at a cell density of approximately 0.2 OD at 600 nm in the wells. The worms were monitored at 12-hour intervals to record complete survival times. Worms unresponsive to external stimuli such as tapping and gentle touches using a worm picker were classified as dead. Mean and maximum lifespans were calculated using GraphPad Prism, and statistical analyses, including P-values determined using the log-rank (Mantel-Cox) statistic, were performed.</p>
</sec>
<sec id="s2_3">
<title>Pharyngeal pumping assay</title>
<p>To assess the frequency of pharyngeal pumping in both control and diabesity-induced <italic>C. elegans</italic>, a total 25 number of worms per biological replicate were placed onto their respective NGM plates seeded with <italic>E. coli</italic> OP50. The quantification of pharyngeal pumping, measured as the number of contractions per 10 seconds, was observed at specific time intervals using a Stereo microscope, following the method outlined by Durai et&#xa0;al. (2013) (<xref ref-type="bibr" rid="B23">23</xref>).</p>
</sec>
<sec id="s2_4">
<title>Motility and thrashing assays</title>
<p>This study utilized N2 nematode strains under two different conditions: Diabesity and standard conditions. The nematodes were cultured on NGM plates containing FUDR regularly. Motility assessments were conducted on the first, fourth, and seventh days of adulthood. Locomotion data were collected and analyzed following the methodology outlined by Rollins et&#xa0;al. (2017) (<xref ref-type="bibr" rid="B24">24</xref>). An hour before video recording, the animals were transferred to fresh NGM plates. Young adult to aged synchronized animals were cultured at 20&#xb0;C for the motility assay. Individual nematodes were tracked, and continuous 1-minute videos were recorded. Wormlab software version 4.1 (MBF Bioscience) (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>) was used to analyze the videos. For each strain studied, 10 videos were captured for subsequent analysis. Differences in motility were assessed using the log-rank test in Graph Pad Prism 6.0 software (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>).</p>
</sec>
<sec id="s2_5">
<title>Nile red staining</title>
<p>To quantify triglyceride accumulation, Nile Red was employed to stain <italic>C. elegans</italic> under both diabesity and standard conditions. Adult worms underwent a series of procedures: initially, they were washed in M9 buffer followed by phosphate-buffered saline (PBS). Subsequently, the worms were fixed in 1% paraformaldehyde at 4&#xb0;C for 1 hour, following the methodology outlined by Escorcia et&#xa0;al. (2018) (<xref ref-type="bibr" rid="B29">29</xref>). Further, the worms were dehydrated using 60% ethanol at room temperature for 15 minutes. The final step involved incubating the worms with a Nile Red staining solution, which consisted of 6 volumes of 1 mg/ml Nile Red in ethanol mixed with 4 volumes of ethanol. This staining process continued for 12 hours as detailed in the protocol by Peng et&#xa0;al. (2016) (<xref ref-type="bibr" rid="B30">30</xref>)</p>
</sec>
<sec id="s2_6">
<title>Quantification of Reactive Oxygen Species (ROS)</title>
<p>The ROS was determined utilizing 2&#x2019;,7&#x2019;-Dichlorofluorescein diacetate (DCF-DA). Nematodes were collected and suspended in 50 &#xb5;l of PBS. Subsequently, 10 &#x3bc;l of a 100 mM DCF-DA solution was introduced to the samples, and incubated in darkness for 15 minutes. Following this, samples were washed with M9 buffer. The worms were paralyzed by adding a 1:100 ratios of 100 mM of sodium azide and subsequently the samples were observed and documented using a Nikon fluorescent microscope (<xref ref-type="bibr" rid="B31">31</xref>).</p>
</sec>
<sec id="s2_7">
<title>Fourier- Transform Infrared (FTIR) spectroscopy analysis</title>
<p>For protein and fatty acid analysis, an equal number of control and diabesity worms were homogenized with 100 mg of potassium bromide. The resulting mixture underwent vacuum drying to form a solid pellet. Using FTIR an infrared spectrum ranging from 400 to 4000 cm<sup>-1</sup> was captured. The obtained data points were plotted, represented intensity against wavenumber, following the methodology detailed by Sethupathy et&#xa0;al. (2017) (<xref ref-type="bibr" rid="B32">32</xref>).</p>
</sec>
<sec id="s2_8">
<title>Quantification of glucose levels using the glucose oxidase- peroxidase method</title>
<p>To ascertain the glucose concentration, the worms were homogenized using the Mini homogenizer MT-13K and centrifuged at 7,500 rpm for 5 minutes to remove the debris. An equivalent concentration of sample was mixed with 1000 &#x3bc;l of Autospan Liquid Gold Glucose reagent, facilitating the quantification of glucose levels through the enzymatic oxidation of glucose. This oxidation process yields gluconic acid and hydrogen peroxide as products. Following a 10-minute incubation period, the color change resulting from the hydrogen peroxide reaction was evaluated using a chromogen. The assessment was performed using a Semi auto analyzer, measuring absorbance at a wavelength of 505 nm (<xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="s2_9">
<title>Estimation of triglyceride levels by GPO method</title>
<p>To evaluate the triglyceride level, an equal concentration of sample was mixed with 1000 &#x3bc;l of triglyceride reagent Liqui CHECK&#x2122;. The enzymatic measurement of triglycerides involved a calorimetric quantification process, where the reaction&#x2019;s intensity was measured at 546/630 nm wavelengths. This assessment was performed using a Semi Auto Analyser system following the methodology outlined by Sullivan et&#xa0;al. (1985) (<xref ref-type="bibr" rid="B34">34</xref>).</p>
</sec>
<sec id="s2_10">
<title>Isolation of lipids using Methyl-tert-butyl-ether method</title>
<p>Approximately 50 x 10<sup>5</sup> worms were used to extract lipids from worms. For each 200 &#x3bc;l sample aliquot, 1.5 ml of methanol was added into glass tubes and vigorously vortexed. Subsequently, 5 ml of MTBE (methyl tert-butyl ether) was added to the mixture, and incubated for one hour incubation at room temperature. Following this, 1.25 ml of MS-grade water was added to the mixture to induce phase separation. The mixture was incubated for 10 minutes at room temperature and then centrifuged at 1,000 g for 10 minutes. The upper (organic) phase was collected, while the lower phase underwent re-extraction as described by Matyash et&#xa0;al., 2008 (<xref ref-type="bibr" rid="B35">35</xref>).</p>
</sec>
<sec id="s2_11">
<title>Thin layer chromatography analysis</title>
<p>The lipid extract analysis using Thin-Layer Chromatography (TLC) was conducted on Merck Silica Gel 60 HPTLC plates measuring 10 &#xd7; 10 cm. The development of silica gel plates was prepared using a solvent mixture comprising n-hexane, diethyl ether, and acetic acid in a ratio of 75:13:9 (v/v/v). To visualize the lipid bands, a spray solution consisting of 20% H<sub>2</sub>SO<sub>4</sub> in ethanol was applied. Subsequently, the plates were charred at a temperature of 200&#xb0;C to visualize the lipid bands, following the method described by Touchstone et&#xa0;al. (1995) (<xref ref-type="bibr" rid="B36">36</xref>).</p>
</sec>
<sec id="s2_12">
<title>Immunofluorescence staining</title>
<p>Tissue sections from frozen blocks of both control and diabesity samples were cut at a thickness ranging from 2 to 4 &#x3bc;m to ensure optimal resolution and placed on microscope slides. Subsequently, 10% neutral buffered formalin (NBF) was applied onto the slides and allowed to incubate for approximately 10 to 15 minutes. Heating at 58&#xb0;C for one hour was conducted for proper preparation of the sections. Following this, the sections underwent deparaffinization and hydration steps. The immunohistochemical process was initiated by fixing the sections with a 4% v/v paraformaldehyde solution in 1X PBS at room temperature. After fixation, the sections were washed twice and then permeabilized using a 0.2% Triton X-100 solution in 1X PBS for 20 minutes at room temperature. Subsequent to permeabilization, the sections were blocked using 2% BSA. After another round of washing, the sections were left to incubate overnight with a primary antibody at a dilution of 1:50, maintained at 4&#xb0;C. Following incubation with the primary antibody, the sections underwent three washes with PBS and were then incubated with secondary antibodies labeled with Alexa Fluor 488 (Invitrogen) for 1 hour at room temperature. A washing step using diluted 1% BSA in 1X PBS for 5 minutes followed this incubation. Digital images were acquired using a fluorescence microscope from Nikon, Japan, and the process was facilitated using Nis-Elements D software (<xref ref-type="bibr" rid="B37">37</xref>)</p>
</sec>
<sec id="s2_13">
<title>LC-MS analysis</title>
<p>The LC-MS analysis was conducted based on the methodology outlined in (<xref ref-type="bibr" rid="B38">38</xref>), with minor adjustments. Initially 200 mM freshly prepared DTT was combined with 200 &#xb5;g of protein per sample in a volume of 100 &#xb5;l. This mixture was incubated in darkness for 1 hour at room temperature. Subsequently, 20 &#xb5;l of 200 mM IAA was added and incubated for 1 hour at a temperature of 56&#xb0;C. Following the addition of 200 mM DTT, the sample underwent an in-solution trypsin digestion using trypsin in 55 mM acetic acid at a 1:50 ratio. The samples were then left to incubate for 16 hours at 37&#xb0;C. For the subsequent LC-MS analysis, an Agilent 6545 ESI-LC/qToF-MS/MS instrument was utilized. Data acquisition was performed using Mass Hunter Workstation software, version B.08.00, while data processing employed Spectrum Mill software, version 06.00. Regarding taxonomic assignment, <italic>C. elegans</italic> was designated as the organism of interest. A mass tolerance of 20 ppm was set for the precursor mass, while the product mass tolerance was established at 600 mDa (<xref ref-type="bibr" rid="B39">39</xref>).</p>
</sec>
<sec id="s2_14">
<title>Protein data analysis</title>
<p>To identify shared proteins within control and diabesity samples protein identification from the LC-MS analysis was subjected to the Venny 2.1.0 tool <italic>(http://bioinfogp.cnb.csic.es/tools/venny/)</italic>, an online platform for creating Venn diagrams. The Gene Ontology (GO) classification of the proteins identified through mass spectrometry was performed using the UniProt database <italic>(http://www.uniprot.org/uploadlist/)</italic> in accordance with the methodology outlined in (<xref ref-type="bibr" rid="B38">38</xref>). To explore the interactions among the identified proteins, the STRING Version 10.5 online tool <italic>(http://string-db.org/)</italic> was utilized. A medium confidence score of 0.400 was employed to assess protein-protein interactions, as described by Balasubramaniam et&#xa0;al. (2020) (<xref ref-type="bibr" rid="B39">39</xref>). Furthermore, the pathways regulated by the identified proteins and gene enrichment analyses were carried out using the KEGG Mapper - search pathway online tool <italic>(http://www.genome.jp/kegg/tool/map_pathway1.html)</italic>. This tool, as described by Pooranachithra et&#xa0;al. (2021) (<xref ref-type="bibr" rid="B40">40</xref>), allowed for the exploration of pathways and gene enrichment associated with the identified proteins.</p>
</sec>
<sec id="s2_15">
<title>Statistical analysis</title>
<p>All the experiments were performed independently in triplicates. Results are represented as mean &#xb1; standard errors of the mean (SEM). The significance of statistical difference was analyzed using one-way ANOVA with Dunnett&#x2019;s multiple comparisons test (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001) in SPSS software version 27.0.1 and GraphPad Prism 9 (<xref ref-type="bibr" rid="B41">41</xref>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Diabesity decreased <italic>C. elegans</italic>, lifespan and pharyngeal pumping</title>
<p>To understand the mechanistic basis of diabesity, <italic>C. elegans</italic> were raised in NGM containing high glucose and cholesterol rich diet (see Methods). It has been reported that growing <italic>C. elegans</italic> on NGM plates containing 40 mM glucose resulted in an intracellular concentration of 14 mM, a range observed in poorly controlled diabetic patients (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B14">14</xref>). In order to understand the impact of diabesity condition generated by high glucose and cholesterol-rich diets in <italic>C. elegans</italic>, the changes were observed in lifespan. The introduction of high glucose and cholesterol-rich diets resulted in a significant reduction in both mean lifespan&#x2014;from 10 &#xb1; 0.6 to 5.5 &#xb1; 0.4 days (P &lt; 0.0001)&#x2014;and maximum lifespan&#x2014;from 21 &#xb1; 0.4 to 10 &#xb1; 0.4 days (P &lt; 0.0001)&#x2014;when compared to the control group fed with <italic>E. coli</italic> OP50 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Physiological assays demonstrating the impact of high glucose and cholesterol on <italic>C. elegans</italic> life span. <bold>(A)</bold> Survival assays revealed a significant decrease in <italic>C. elegans</italic> lifespan under diabesity conditions compared to the control with <italic>E. coli</italic> OP50. Kaplan-Meier survival curves were compared using the Mantel-Cox log-rank test. The maximum reduction in lifespan was observed at 60% compared to controls (P &lt; 0.0001, n = 160). <bold>(B)</bold> <italic>C. elega</italic>ns cultured on agar supplemented with 100 mM glucose and 25 &#x3bc;M cholesterol showed altered median lifespan (day 5th of adulthood), and concentrations of glucose and cholesterol were quantified in whole-body extracts at this stage. Results represent the means of three biological experiments and were assessed using a t-test (*P &gt; 0.05, **P &lt; 0.001, and ***P &lt; 0.0001) to compare the two groups. <bold>(C)</bold> Pharyngeal pumping of <italic>C. elegans</italic> significantly decreased under diabesity conditions from day 2 of adulthood. The experiment was conducted in triplicate. Results are from a representative experiment out of three biological experiments, each involving more than 80 nematodes. *Statistical differences were considered significant at p &lt; 0.05 <bold>(D)</bold> Body size of <italic>C. elegans</italic> significantly increased under diabesity conditions.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1383520-g001.tif"/>
</fig>
<p>For the analysis of intracellular glucose and cholesterol concentrations at the mean lifespan (day 5 of adulthood), whole-body extracts from <italic>C. elegans</italic> were examined. Culturing <italic>C. elegans</italic> on agar plates containing 100 mM glucose and 25 &#x3bc;M cholesterol under diabesity conditions resulted in intracellular concentrations of 48 mM glucose and 15 &#x3bc;M cholesterol (P &lt; 0.001, n=50), notably higher than the control worms&#x2019; levels at 11 &#xb1; 4 mM glucose and 2 &#xb1; 1 &#x3bc;M cholesterol (P &lt; 0.0001, n=50) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>).Under standard conditions, no supplementary glucose is introduced into the nematode growth medium. However, in all subsequent experiments, the high glucose and cholesterol conditions for <italic>C. elegans</italic> refer to concentrations of 100 mM glucose and 25 &#x3bc;M cholesterol, respectively. This distinction was crucial in assessing the consequences of diabesity conditions induced by these dietary components in <italic>C. elegans</italic>. In addition, when compared to the control group, the pharyngeal pumping of diabesity <italic>C. elegans</italic> progressively decreases starting from day 2 of adulthood (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). After day 6<sup>th</sup> of adulthood, all other physiological activities also progressively decreased until <italic>C. elegans</italic> becomes immobile. Compared to the control, diabesity worms exhibit other defective physiological characteristics such as a fattened body and apathetic behavior (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Each experiment was conducted in biological triplicate, and the error bars represent the mean &#xb1; SEM (p &lt; 0.005).</p>
</sec>
<sec id="s3_2">
<title>Nile red staining showed high lipid species deposition in diabesity worms</title>
<p>Due to the absence of adipocytes, <italic>C. elegans</italic> stores its fat in small droplet-like organelles referred to as lipid droplets, predominantly located in the intestine and hypodermis (<xref ref-type="bibr" rid="B42">42</xref>). To investigate the impact of high glucose and cholesterol on lipid droplets accumulation in <italic>C. elegans</italic>, Nile red staining was conducted. This staining method targets neutral lipids such as triglycerides or cholesterol esters. The fluorescence from Nile red staining was quantified using ImageJ software. The supplementation of high glucose to the NGM resulted in a significant increase in lipid accumulation in diabesity samples compared to the control (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>), consistent with previous findings that used glucose as an obesogenic stimulus in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Intracellular fat droplets in <italic>C. elegans</italic> were visualized using fluorescence microscopy (<xref ref-type="bibr" rid="B45">45</xref>), and the present study revealed a notable increase in fat and lipid storage within adipose tissues in the diabesity condition and no significant fluorescence was observed in control (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Analysis of <italic>C. elegans</italic> lipid accumulation using Nile red staining. <bold>(A)</bold> A representative fluorescent micrograph of Nile red staining depicts the distribution and accumulation of lipid droplets in <italic>C. elegans</italic> under diabesity and control conditions. <bold>(B)</bold> Quantitative analysis of Nile red staining using ImageJ software, confirms that compared to control and other conditions, diabesity-induced animals exhibit higher lipid deposition. <bold>(C)</bold> A representative fluorescent micrograph of Nile red staining depicts the isolated lipid droplets from <italic>C. elegans</italic> under diabesity and control conditions. <bold>(D)</bold> Estimation of triglycerides shows they are significantly high in diabesity animals compared to control (P&lt; 0.0001). <bold>(E)</bold> A quantitative analysis of thin-layer chromatography confirms that, in comparison to the control group, animals under diabesity conditions exhibit higher percentages of triglycerides, cholesterol esters, sphingomyelin, and phospholipids compared to control (P&lt; 0.0001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1383520-g002.tif"/>
</fig>
<p>Furthermore, the quantification of triglycerides indicated a substantial elevation in diabesity samples compared to the control. Triglyceride levels were assessed at day 2, 4, and 6 of adulthood. At day 2 of adulthood, diabesity animals exhibited approximately 369 &#xb1; 1 ng of triglycerides compared to 170 &#xb1; 3 ng in the control (P&lt; 0.0001). By day 4 of adulthood, diabesity animals showed 520 &#xb1; 5 ng compared to 188 &#xb1; 5 ng in the control (P&lt; 0.0001, n=500). Finally, at day 6 of adulthood, diabesity animals displayed 740 &#xb1; 1 ng of triglycerides, whereas the control exhibited 300 ng (P&lt; 0.001, n=500) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>). In this study, we have also conducted the separation of lipid extracts through thin-layer chromatography following the standard procedure (see methods). Our results demonstrate a significant increase of triglycerides, cholesterol esters, and notably higher amounts of glycolipid species (Sphingomyelin and Phospholipids) in diabesity animals compared to the control group (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure S1</bold>
</xref>). The proportional content analysis from each lane of the TLC plates was performed by densitometry of digital photographs using ImageJ software (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). Each experiment was conducted in biological triplicates, and the error bars represent the mean &#xb1; SEM (p &lt; 0.001).</p>
</sec>
<sec id="s3_3">
<title>Diabesity induced oxidative stress alter cellular components (lipids and proteins)</title>
<p>Lipid peroxidation has been observed to be higher in obese individual mice compared to non-obese (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). Hyperglycemia results in elevated levels of reactive oxygen species (ROS) production through the polyol pathway, leading to the formation of advanced glycation end products (AGEs) and causing significant oxidative stress (<xref ref-type="bibr" rid="B48">48</xref>). Assessing ROS levels serves as an effective means to quantify oxidative damage resulting from hyperglycemia. In this study, we measured ROS levels using H<sub>2</sub>DCFDA staining. ROS induction was examined at day 5<sup>th</sup> of adulthood. We found a higher generation of ROS in worms exposed to diabesity conditions, whereas no significant fluorescence was observed in the control sample (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Diabesity animals exhibit elevated levels of ROS production and impacting cellular components (Lipids and proteins). <bold>(A)</bold> Assessment of ROS levels using H<sub>2</sub>DCFDA staining on day 5th of adulthood demonstrates the percentage of ROS generation in diabesity worms through micrograph analysis. <bold>(B)</bold> Quantitative analysis of the ROS micrographs using ImageJ software. Shown are animals from a representative experiment out of 4 biological independent experiments, each including 30 worms <bold>(C)</bold> FT-IR analysis of <italic>C. elegans</italic> lipids and proteins. The average FT-IR spectra of the diabesity showed major signature peak difference at 3,000&#x2013;2,800 cm<sup>&#x2212;1</sup>, 1800-1500 cm<sup>&#x2212;1</sup> and 1200 -900 cm<sup>&#x2212;1</sup>, these regions belong to fatty acids, carbohydrate bands, carbonyl stretching and vibration of the lipids respectively. Data were expressed as mean value of three experiments and the error bars represent SEM &#xb1; mean (*<italic>p</italic> &lt; 0.05).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1383520-g003.tif"/>
</fig>
<p>The application of FT-IR spectroscopy has proven to be a valuable tool for investigating biomolecular complex structures within cells (<xref ref-type="bibr" rid="B49">49</xref>). In the context of examining the impact of oxidative stress induced by diabesity on <italic>C. elegans</italic> lipids and proteins, FT-IR analysis revealed significant differences in intensity peaks between diabesity samples and the control group. Specifically, the analysis of <italic>C. elegans&#x2019;</italic> fatty acids exhibited distinct intensity peaks at various wavelengths: 3000-2800 cm<sup>-1</sup>, 3100 cm<sup>-1</sup>, and 2930 cm<sup>-1</sup>. These peaks correspond to fatty acids, N-H stretching of proteins associated with lipids, and CH<sub>2</sub> anti-symmetric stretching of lipids, respectively (<xref ref-type="bibr" rid="B50">50</xref>&#x2013;<xref ref-type="bibr" rid="B52">52</xref>) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). Additionally, the protein FT-IR spectroscopy analysis depicted features such as carbonyl stretching (1800 - 1500 cm<sup>-1</sup>), vibration of Amide I and Amide II bands of proteins (1740 cm<sup>-1</sup>), and broadening of the peak at 1650 cm<sup>-1</sup>, suggesting protein oxidation (<xref ref-type="bibr" rid="B53">53</xref>&#x2013;<xref ref-type="bibr" rid="B55">55</xref>). Furthermore, noticeable differences in intensity were observed in the 1200-900 cm<sup>-1</sup> range, associated with carbohydrate bands (<xref ref-type="bibr" rid="B56">56</xref>&#x2013;<xref ref-type="bibr" rid="B58">58</xref>). These spectral differences in the <italic>C. elegans</italic> fatty acid and protein region imply the impact of stress induced by high diabesity conditions on cellular molecules. Moreover, differences in protein FT-IR spectroscopy indicate variations in protein glycosylation. Changes in protein glycosylation have been linked to various physiological and pathological conditions, such as tumor invasion, cell growth differentiation, host-pathogen interaction, cell trafficking, and transmembrane signaling (<xref ref-type="bibr" rid="B59">59</xref>).</p>
</sec>
<sec id="s3_4">
<title>Diabesity condition reduced locomotion in <italic>C. elegans</italic>
</title>
<p>High glucose causes susceptible to cognitive impairment, progression of Alzheimer&#x2019;s disease and decreases the locomotor activity (<xref ref-type="bibr" rid="B60">60</xref>&#x2013;<xref ref-type="bibr" rid="B64">64</xref>). The motility of <italic>C. elegans</italic> is regulated by acetylcholine receptors, which plays important role in synaptic functions (<xref ref-type="bibr" rid="B65">65</xref>). The ability to move relies on neuronal signaling, maintenance of muscle mass, and integrity of connective tissue (<xref ref-type="bibr" rid="B66">66</xref>&#x2013;<xref ref-type="bibr" rid="B69">69</xref>). Consequently, motility serves as a valuable indicator for evaluating the neurotransmission and is a useful marker to assess health span (<xref ref-type="bibr" rid="B70">70</xref>). The motility assays conducted in our study were devised to investigate the intricate connections between high glucose and locomotor behavior. Our study involved the examination of changes in motility at two distinct time points: day-3 and day-6 of adulthood. We conducted these assessments in both under standard conditions and diabesity condition. We utilized MATLAB worm tracking software to analyze quantitative data obtained from video recordings of motility (see Methods). At both day 3 and day 6 of adulthood, nematodes experiencing the diabesity condition displayed decreased motility compared to those in standard conditions (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Additionally, worms under standard conditions displayed a notably higher frequency of thrashing movements than those in the diabesity condition (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). The dopamine signaling in <italic>C. elegans</italic> is responsible for the gait transition from swim to crawl (<xref ref-type="bibr" rid="B71">71</xref>). Studies using ontogenetic confirmed D1-like dopamine receptors switch animals, away from the bacterial food source (<xref ref-type="bibr" rid="B72">72</xref>&#x2013;<xref ref-type="bibr" rid="B74">74</xref>). In our studies diabesity condition, nematodes move off from the food source <italic>E. coli</italic> OP50 bacteria, compared to those under standard conditions (data not shown).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Evaluation of motility and thrashing of diabesity and control worms: The motility of <italic>C. elegans</italic> treated with high glucose and cholesterol was assessed while analyzing the video recording (See Methods). Speed and thrashing moments was measurements were at three different time points (day 1, 4th, and 7th day) of adulthood. (<bold>A, B</bold>) Motility and Thrashing moments of diabesity and control worm respectively. For each experiment, over ~40 worms were tracked for 60 seconds. Scatter plots depict bars representing the mean and standard error of the mean for all conditions. Statistical comparisons were conducted using one-way ANOVA with Dunnett&#x2019;s multiple comparisons test (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001)).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1383520-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Proteomic analysis of diabesity model</title>
<p>The results obtained from physiological assays prompted further investigation into the primary molecular mechanisms underlying <italic>C. elegans</italic> diabesity. LC-MS-based proteomic analyses were conducted in biological triplicates to ensure the robustness and reproducibility of the results. Following Post-MS Data analysis for protein identification and expression, a total of 627 differentially regulated proteins were detected. We set the relative expression ratio for downregulated and upregulated proteins between control and treated samples at &#x2265;-1.5 and &#x2265;1.5, respectively, across all biological replicates (p &lt; 0.05). Out of these, 18 proteins were common with 10 being down regulated and 8 being up regulated significantly. Detailed information on these differentially regulated proteins can be found in <xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Tables S1</bold>
</xref>, <xref ref-type="supplementary-material" rid="SF3">
<bold>S2</bold>
</xref>. Subsequently, the high-throughput protein profile and expression data underwent comprehensive bioinformatics analysis. To assign potential physiological functions to the regulated proteins, a Gene Ontology (GO) annotation and functional enrichment analysis were performed using the UniProtKB tool. The differentially regulated proteins were categorized into molecular functions, biological processes, and cellular components. Based on the GO functional annotation, the major group of regulated proteins in diabesity is associated with response to stimuli and cellular processes. Additionally, genes related to locomotion, localization, immune system processes, responses to stimuli, and signaling pathways exhibit regulatory changes. The primary biological processes predominantly affected among the differentially regulated proteins include metabolic processes and cellular activities (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A, B</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Bioinformatics analysis of Proteomics Data. <bold>(A, B)</bold> Gene ontology analysis using the UniProtKB online tool showed regulated proteins are involved in cellular processes, locomotion, immune system processes, responses to stimuli, and signaling pathways. <bold>(C)</bold> Functional annotations and protein enrichment scores of regulated proteins was performed using the DAVID tool. The biological functions which have more number of regulated proteins binding, catalytic activity, and transport activity. <bold>(D)</bold> Interactome map among regulated proteins was performed using STRING tool with a median confidence threshold score (0.400). The interaction map showed link between identified regulated proteins of <italic>C. elegans</italic>. The regulated proteins showed interaction among Toll-like receptor (TLR) activation, plasma lipoprotein remodeling, serine biosynthesis, LDL clearance, lipid transporter activity, and unblocking of NMDA receptors. <bold>(E)</bold> KEGG pathway analysis shows regulated proteins were predominantly associated with pathways such as the insulin/IGF pathway, Alzheimer&#x2019;s disease pathway, and nicotinic acetylcholine receptor signaling pathways.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1383520-g005.tif"/>
</fig>
<p>The functional annotation and gene enrichment of all regulated proteins were conducted using the DAVID tool. Functional annotation delineates the role of individual proteins across various biological processes. Among the biological functions exhibiting the highest numbers of differentially regulated proteins between the control and diabesity conditions were binding and catalytic processes. Notably, transporter activity genes showed an upregulation in diabesity compared to the control, as illustrated in (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). In diabesity, proteins responsible for signaling receptor activity, nutrient reservoir activity, fusogenic activity, cytoskeletal motor activity, and transcription coactivator activity were observed to be downregulated when compared to the control.</p>
<p>The interactome network was constructed using the STRING tool to analyze regulated proteins, investigating their interactions and predicting functional associations. The resulting interaction map of regulated proteins illustrates the relationships among molecular players involved in Toll-like receptor (TLR) activation by endogenous ligands, plasma lipoprotein remodeling, serine biosynthesis, LDL clearance, lipid transporter activity, and unblocking of NMDA receptors (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). These proteins are interconnected, either directly interacting with one another or indirectly through their partners. Moreover, employing the STRING tool helped in identifying potential dysregulated KEGG pathways associated with diabesity. Subsequently, KEGG pathway analysis unveiled that differentially regulated proteins were predominantly associated with pathways such as the insulin/IGF pathway, Alzheimer&#x2019;s disease pathway, nicotinic acetylcholine receptor signaling pathways, and the P53 pathway. The pathways most significantly regulated in diabesity are depicted in (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>).</p>
</sec>
<sec id="s3_6">
<title>Diabesity decreases collagen production and disruptions anatomical structures</title>
<p>In mice lacking collagen, the development of insulin resistance and glucose intolerance occurs, accompanied by elevated serum triglycerides and fat accumulation (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>). In <italic>C. elegans</italic>, deficiency in ATGL-1 results in elevated lipid content and shortened lifespan. Despite ATGL-1 being identified as a cytosolic lipase, nuclear morphology deterioration is not rescued upon upregulation of ATGL-1 (<xref ref-type="bibr" rid="B77">77</xref>). In our studies, we observed a noteworthy increase in lipid droplets and triglycerides within diabesity models (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). The accumulation of triglycerides during diabesity is linked to ATGL-1 deficiency, preventing their hydrolysis and leading to their encapsulation in lipid droplets. Consequently, organelles undergo enlargement due to this accumulation.</p>
<p>In this study, one of the focuses was isolation and estimation of <italic>C. elegans</italic> collagen (see methods). Our investigation into diabesity revealed a significant reduction in collagen levels at the 4<sup>th</sup> and 6<sup>th</sup> days of adulthood compared to the control group. Specifically, control specimens exhibited 80 ng/50 mg (4<sup>th</sup> day) and 120 ng/50 mg (6<sup>th</sup> day), while diabesity-afflicted animals demonstrated 50 ng/50 mg and 70 ng/50 mg respectively (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). Notably, no substantial changes were observed at day 2 of adulthood. These findings emphasize the influence of diabesity on collagen production within the <italic>C. elegans</italic> model, indicating a potential interplay between metabolic disorders and collagen regulation. The reduced collagen levels could lead to disruptions in anatomical structure and its integrity, due to sustained elevated levels of glucose and triglycerides. To validate these abnormalities, our microscopic analysis of control sections exhibited well-defined epidermal and cuticle layers, including specialized worm body structures such as the hemidesmosomes layer. Conversely, in diabesity, these specialized features like cuticles and hemidesmosomes were less distinct and displayed compromised mechanical strength (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6B, C</bold>
</xref>). Immunofluorescence staining was conducted to visualize the distribution and subcellular localization of ATGL-1 (see Methods). The results revealed a predominant presence of ATGL-1 in the epidermal region and hemidesmosomes in the control group. Conversely, in diabesity-induced conditions, its presence showed inconsistency across the cuticle layer, hypodermal areas, and distal gonad. These findings confirm the inhibition of ATGL-1&#x2019;s lipolytic activity in diabesity-induced worms (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Impact of diabesity on collagen and worm body structures. <bold>(A)</bold> Estimation of total collagen were measured at three distinct time points (day 2, 4<sup>th</sup>, and 6<sup>th</sup> day) during adulthood using a total of over 10,000 worms per experiment. The results present the means derived from three separate biological experiments and were statistically analyzed via a t-test (*p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001) to compare diabesity and control groups. <bold>(B)</bold> The <italic>C. elegans</italic> transverse section image depicts tissue structure differences within diabesity and control worms; Scale bar- 100&#x3bc;m <bold>(C)</bold> The <italic>C. elegans</italic> transverse sections under bright field and stained with Nile red to observe the lipid droplet distribution in diabesity condition compared to the control groups; Scale bar- 50&#x3bc;m. <bold>(D)</bold> Tissue sections represent the overall distribution of ATGL in control and diabesity condition using ALEXA fluor 488. The green color delineates the presence of ATGL along with structural differences, showing notable changes in specific aspects of the worm&#x2019;s body structure. The white arrows represent the presence of ATGL in diabesity compared to control groups; Scale bar- 100&#x3bc;m.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1383520-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Decades of research on diabesity have unveiled the central players participating as age-related regulatory pathways in <italic>C. elegans</italic>. However, the specific role of lipid droplets in governing lifespan and metabolic disorders has remained elusive. Initial findings have indicated a complex and intricate pathophysiological reaction in <italic>C. elegans</italic> triggered by the supplementation of high glucose and cholesterol. This supplementation has led to conditions such as obesity, hyperglycaemia, as well as collagen and glycation impairment &#x2013; the classic indicators of metabolic disorders, particularly in diabesity. <italic>C. elegans</italic> serves as an appropriate model organism for studying human metabolic disorders, including obesity (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>). Given the similarity between <italic>C. elegans</italic> lipid and carbohydrate metabolism and those observed in mammals, alongside its fully sequenced genome, this tiny nematode serves as an ideal <italic>in vivo</italic> model for studying diabesity. High levels of glucose and cholesterol tend to disrupt cellular homeostasis, increase oxidative stress, and shorten lifespan in organisms such as mice and drosophila (<xref ref-type="bibr" rid="B80">80</xref>). In this study, the introduction of high levels of glucose and cholesterol shortened the lifespan of <italic>C. elegans</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), increased its body length, compromised locomotion, and affected pharyngeal pumping (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1C, D</bold>
</xref>). These outcomes highlight the adverse effects of over-nutrition on the organism&#x2019;s health. Diets high in glucose have been shown to increase fat deposition and TAG storage in rodents, fruit flies, and zebrafish, mirroring observations in worms. This research aids in understanding metabolic diseases and the impact of dietary choices on health (<xref ref-type="bibr" rid="B81">81</xref>). Supplementation of NGM medium with high percentage of glucose resulted in increased fat deposition and TAG storage in worms, revealing heightened variability in comparison to the control group (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B</bold>
</xref>, <xref ref-type="fig" rid="f2">
<bold>2E</bold>
</xref>).</p>
<p>Elevated ROS production appears to play a significant role in the aging process (<xref ref-type="bibr" rid="B82">82</xref>). Lipofuscin, an indicator of both oxidative stress and aging in <italic>C. eleg</italic>ans, is an auto fluorescent pigment that gradually accumulates over time (<xref ref-type="bibr" rid="B83">83</xref>), particularly within lysosomes and gut granules of the intestine (<xref ref-type="bibr" rid="B84">84</xref>). In our study a higher level of ROS was observed in the diabesity condition. This aligns with reports suggesting that metabolic overload associated with obesity and T2DM, characterized by elevated levels of glucose and free fatty acids (FFA), leads to increased intracellular accumulation of ROS in models such as mice also showed heightened oxidative stress and accumulation of lipofuscin when glucose levels were elevated (<xref ref-type="bibr" rid="B85">85</xref>). In our immunofluorescence assay, we observed increased lipofuscin accumulation following glucose treatment, consistent with the observed generation of ROS (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A-C</bold>
</xref>) The TAGs constitute the primary component of lipid droplets, serving as efficient energy reservoirs within <italic>C. elegans</italic> (<xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>). The control mechanisms governing lipid storage have been discerned to revolve around lipid droplets, a phenomenon intertwined with significant metabolic disorders such as diabetes and obesity. Notably, the emergence of insulin resistance in <italic>C. elegans</italic> appears to occur through mechanisms that are conserved across evolution. This observation is underscored by the resemblance in transcriptional responses triggered by elevated levels of glucose and lipids, which involve analogous insulin/IGF-1-like signaling pathways found in humans (<xref ref-type="bibr" rid="B88">88</xref>). The proteomic data in the present study showed the insulin-like receptor pathway is among one which has activated in diabesity animals; this is central pathways involved in life span determination. The association between type 2 diabetes and various neurodegenerative conditions has been extensively reported (<xref ref-type="bibr" rid="B89">89</xref>&#x2013;<xref ref-type="bibr" rid="B91">91</xref>). Previous studies have indicated that individuals with high glycemic indexes are more susceptible to developing these diseases, highlighting a probable prevalence of insulin resistance among these patients (<xref ref-type="bibr" rid="B92">92</xref>). According to (<xref ref-type="bibr" rid="B15">15</xref>), a mechanism wherein a high-glucose diet triggers DAF-2-independent regulation of lifespan in <italic>C. elegans</italic>. This independent regulation of body movement (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A, B</bold>
</xref>) and increased body size in a DAF-independent manner bolsters the notion of alternative pathways being activated by high concentrations of glucose.</p>
<p>The interactions between lipid metabolisms highlight the pivotal role of lipid metabolism in maintaining tissue integrity and cellular homeostasis. LD formation and turnover are closely regulated by factors such as hormones (like insulin), dietary lipids, and metabolic conditions (such as fasting versus feeding) in organisms such as mice and Drosophila (<xref ref-type="bibr" rid="B93">93</xref>). The interplay becomes particularly evident through the formation of lipid droplets (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A-C</bold>
</xref>), primilarly via <italic>de novo</italic> synthesis within the ER (<xref ref-type="bibr" rid="B94">94</xref>). A recent investigation has elucidated the presence of nuclear fat in intestinal and adipose tissues, orchestrating various facets of their physiological functions in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="B95">95</xref>). The gene ontology analyses conducted in this study have provided insights into the differential regulation of these specific pathways (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A-E</bold>
</xref>). Furthermore, the protein-protein interaction map has illuminated the complex interrelationships among the previously mentioned proteins, emphasizing their pivotal roles in diverse metabolic, structural, and cellular functions. Overall, the findings obtained from proteomics and the subsequent validation experiments suggest a hypothesis that the expression of several crucial proteins, particularly those involved in the insulin/IGF- like signaling pathway, glycolysis, metabolic process, and cell adhesion, were subject to regulation that potentially contributes to the development of diabesity (<xref ref-type="bibr" rid="B96">96</xref>).</p>
<p>The presence of a hypoglycaemic and hypolipidemic environment induces the formation of disorganized collagen fibrils due to the presence of AGE products, leading to reduced skin elasticity, diminished thickness, collagen denaturation, and altered plasticity (<xref ref-type="bibr" rid="B97">97</xref>). Indeed, the results of the present study are in line with recent research that highlights the connection between diabetes, obesity, and disruptions in collagen structure and metabolism. Accumulations of over-glycosylated collagens and alterations in the concentrations of sulphated proteoglycan have been implicated in these conditions. These changes in collagen composition and proteoglycan concentrations can lead to morphological alterations such as basement membrane thickening (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>). This underscores the complex interplay between metabolic disorders, such as diabetes and obesity, and their impact on the structural integrity of tissues, particularly collagen-rich structures (<xref ref-type="bibr" rid="B98">98</xref>). Notably, AGEs form through a non-enzymatic reaction between sugars and proteins/lipids, accumulating in tissues, especially in diabetes, leading to reduced collagen production and structural disruptions. AGEs can cross-link collagen fibers, altering their structure and function. This cross-linking process, known as glycation, stiffens collagen and reduces its flexibility. It contributes to the pathological changes observed in tissues affected by diabetes, such as vascular complications and skin aging (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>). ATGL expression serves as a regulatory element in the balance of glucose and lipid metabolism, playing a significant part in the development of lipotoxicity during diabesity in <italic>C. elegans</italic>. Reports consistently validate that lipolysis, a pivotal aspect of fat metabolism, is regulated by multiple crucial factors. Among these, ATGL-1 stands out as a central enzyme accountable for catalyzing the hydrolysis of triglycerides (TAGs) into fatty acids (<xref ref-type="bibr" rid="B76">76</xref>). Current studies affirm ATGL-1&#x2019;s role in diabesity as a key factor in lipolysis regulation. Deactivating ATGL-1 doesn&#x2019;t promote longevity in diabesity, suggesting its turnover function. It&#x2019;s transcriptionally regulated, preserving lipid droplet homeostasis in nuclear compartments with aging, reinforcing its pivotal role in diabesity-related lipolysis regulation (<xref ref-type="bibr" rid="B100">100</xref>). Notably, the mitigation of lipotoxic lipid accumulation hinges on the activity of the triglyceride lipase ATGL-1 within the intestinal nuclei. Further corroborating the pivotal role of ATGL-1 in organismal equilibrium and tissue functioning, its upregulation effectively sustains LDs and even contributes to an extension of lifespan (<xref ref-type="bibr" rid="B101">101</xref>). ATGL-1 deficiency leads to the enlargement of LDs within the intestinal cells of diabesity-affected <italic>C. elegans</italic> when compared to the control. Moreover, immunofluorescence findings revealed that ATGL was primarily concentrated in the epidermal region. It was inconsistently present in the cuticle layer, distinct hypodermal regions, and the distal gonad at endogenous levels in control comparison to diabesity (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6C, D</bold>
</xref>). The intricate link between ATGL-1 deficiency, LD morphology, and diabesity&#x2019;s metabolic disruptions is highlighted here. These findings reinforce the crucial role of lipid-droplet-mediated protein degradation in longevity and aging. They support the hypothesis that lipid droplets maintain cellular balance by stabilizing proteomes and organizing protein degradation machinery, suggesting their pivotal role in cellular homeostasis. In conclusion this study highlights ATGL&#x2019;s significant impact on protein function, influencing both lipid and glucose processes, and upregulating genes associated with glucose metabolism (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). In conditions like diabesity, inhibiting ATGL disrupts glycolysis, lipid formation, fatty acid oxidation, and influences aging, all processes reliant on ATGL. This positions ATGL as a crucial contributor in diabesity within <italic>C. elegans</italic>, potentially serving as a biomarker. However, a more comprehensive understanding of ATGL&#x2019;s specific role within the metabolic framework of diabesity necessitates further investigation.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Overall schematic representation of diabesity in <italic>C. elegans</italic>. ATGL dysfunction in diabesity leads to a combination of hyperglycemia and dyslipidemia, resulting in the loss of neuronal signals, increased oxidative stress, and advanced glycation end-products. These disruptions in metabolism elevate free fatty acids, leading to higher lipid accumulation. Concurrently, impaired lipid metabolism and ATGL dysfunction induce endoplasmic reticulum (ER) stress, compromising structural integrity, particularly collagen. The supplementation of glucose with cholesterol-rich diets collectively reduces lifespan by accelerating both glucotoxicity and lipotoxicity, culminating in mitochondrial dysfunction.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1383520-g007.tif"/>
</fig>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://www.ebi.ac.uk/pride/">https://www.ebi.ac.uk/pride/</uri>, accession number: PXD057033.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>MSu: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. DM: Conceptualization, Data curation, Formal analysis, Methodology, Writing &#x2013; review &amp; editing. KA: Data curation, Formal analysis, Conceptualization, Writing &#x2013; original draft. MSi: Formal analysis, Writing &#x2013; original draft. HD: Formal analysis, Software, Writing &#x2013; original draft. VR: Resources, Software, Writing &#x2013; original draft. KB: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>MS acknowledges Rastriya Uchchatar Shiksha Abhiyan (RUSA) - phase 2.0, Government of India [F. 24-51/2014-U, Policy (TN Multi-Gen), Dept of Edn, GOI] for RUSA 2.0 Fellowship. We sincerely express gratitude to provide Proteomic Core Facility, National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, West Bengal, India for LCMS facility. The authors acknowledge DBT, DST-SERB, and ITC for providing the infrastructure and instrumentation facilities. The authors also acknowledge USIC, ALU for providing the instrumentation for characterization studies.</p>
</ack>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2024.1383520/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2024.1383520/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF1" mimetype="application/pdf">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Analysis of lipids using thin layer chromatography of control and diabesity protein along with standard.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF2" mimetype="application/pdf">
<label>Supplementary Table&#xa0;1</label>
<caption>
<p>List of down regulated proteins present in Control and Diabesity animals identified using LC-MS.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF3" mimetype="application/pdf">
<label>Supplementary Table&#xa0;2</label>
<caption>
<p>List of up regulated proteins present in Control and Diabesity animals identified using LC-MS.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF4" mimetype="application/pdf">
<label>Supplementary Table&#xa0;3</label>
<caption>
<p>Chemical list used for the study.</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haslam</surname> <given-names>DW</given-names>
</name>
<name>
<surname>James</surname> <given-names>WP</given-names>
</name>
</person-group>. (<year>2005</year>). <article-title>Diastolic dysfunction and left ventricle remodeling in men with impaired fasting glucose</article-title> <source>Obes Lancet.</source> <volume>366</volume>:<page-range>1197&#x2013;1209</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(05)67483-1</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Sims Ethan</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Jr</surname> <given-names>ED</given-names>
</name>
<name>
<surname>Horton</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Bray</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Glennon</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Salans</surname> <given-names>XXXL. B</given-names>
</name>
</person-group>. (<year>1973</year>). <article-title>Endocrine and metabolic effects of experimental obesity in man</article-title>, in: <conf-name>Proceedings of the 1972 Laurentian Hormone Conference</conf-name>, . pp. <page-range>457&#x2013;96</page-range>. <publisher-name>Academic Press</publisher-name>.</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Susana</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moreira</surname> <given-names>PI</given-names>
</name>
</person-group>. <article-title>Diabesity and brain disturbances: A metabolic perspective</article-title>. <source>Mol aspects Med</source>. (<year>2019</year>) <volume>66</volume>:<page-range>71&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mam.2018.10.002</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng Arnold</surname> <given-names>CT</given-names>
</name>
<name>
<surname>Delgado</surname> <given-names>V</given-names>
</name>
<name>
<surname>Borlaug</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Bax</surname> <given-names>JJ</given-names>
</name>
</person-group>. <article-title>Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging</article-title>. <source>Nat Rev Cardiol</source>. (<year>2021</year>) <volume>4</volume>:<fpage>291</fpage>&#x2013;<lpage>304</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41569-020-00465-5</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcelo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fuentes</surname> <given-names>G</given-names>
</name>
<name>
<surname>Valero</surname> <given-names>P</given-names>
</name>
<name>
<surname>Vega</surname> <given-names>Sof&#xed;a</given-names>
</name>
<name>
<surname>Grismaldo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Toledo</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Gestational diabesity and foetoplacental vascular dysfunction</article-title>. <source>Acta Physiologica</source>. (<year>2021</year>) <volume>4</volume>:<fpage>e13671</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/apha.13671</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boden</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes</article-title>. <source>J Clin Invest</source>. (<year>1995</year>) <volume>96</volume>:<page-range>1261&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI118160</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boden</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>45Obesity, insulin resistance and free fatty acids</article-title>. <source>Curr Opin endocrinology diabetes Obes</source>. (<year>2011</year>) <volume>18</volume>:<fpage>p.139</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MED.0b013e3283444b09</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olesja</surname> <given-names>R</given-names>
</name>
<name>
<surname>Jelenik</surname> <given-names>T</given-names>
</name>
<name>
<surname>Roden</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Lipid-mediated muscle insulin resistance: different fat, different pathways</article-title>? <source>J Mol Med</source>. (<year>2015</year>) <volume>93</volume>:<page-range>831&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00109-015-1310-2</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>American Diabetes Association Professional Practice Committee</collab>
</person-group>. <article-title>11. Chronic kidney disease and risk management: standards of medical care in diabetes&#x2014;2022</article-title>. <source>Diabetes Care</source>. (<year>2022</year>) <volume>45</volume>:<page-range>S175&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/dc22-S011</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappachan Joseph</surname> <given-names>M</given-names>
</name>
<name>
<surname>Viswanath</surname> <given-names>AK</given-names>
</name>
</person-group>. <article-title>Medical management of diabesity: do we have realistic targets</article-title>? <source>Curr Diabetes Rep</source>. (<year>2017</year>) <volume>17</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>.</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Khoury</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chouillard</surname> <given-names>E</given-names>
</name>
<name>
<surname>Chahine</surname> <given-names>E</given-names>
</name>
<name>
<surname>Saikaly</surname> <given-names>E</given-names>
</name>
<name>
<surname>Debs</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kassir</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Metabolic surgery and diabesity: a systematic review</article-title>. <source>Obes Surg</source>. (<year>2018</year>) <volume>28</volume>:<page-range>2069&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11695-018-3252-6</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlotterer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kukudov</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bozorgmehr</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hutter</surname> <given-names>H</given-names>
</name>
<name>
<surname>Du</surname> <given-names>X</given-names>
</name>
<name>
<surname>Oikonomou</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>C. <italic>elegans</italic> as model for the study of high glucose&#x2013;mediated life span reduction</article-title>. <source>Diabetes</source>. (<year>2009</year>) <volume>58</volume>:<page-range>2450&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db09-0567</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Min</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Do</surname> <given-names>C-H</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>Taurine reduces ER stress in C. elegans</article-title>. <source>J Biomed Sci</source>. (<year>2010</year>) <volume>17</volume>:<fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1423-0127-17-S1-S26</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Guzman Arvie Camille</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>EJi</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JHo</given-names>
</name>
<name>
<surname>Jang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>JH</given-names>
</name>
<etal/>
</person-group>. <article-title>High-glucose diet attenuates the dopaminergic neuronal function in c. elegans, leading to the acceleration of the aging process</article-title>. <source>ACS omega</source>. (<year>2022</year>) <volume>36</volume>:<page-range>32339&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acsomega</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawlor</surname> <given-names>N</given-names>
</name>
<name>
<surname>Khetan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ucar</surname> <given-names>D</given-names>
</name>
<name>
<surname>Stitzel</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>Genomics of islet (dys) function and type 2 diabetes</article-title>. <source>Trends Genet</source>. (<year>2017</year>) <volume>33</volume>:<page-range>pp.244&#x2013;255</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tig.2017.01.010</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loos Ruth</surname> <given-names>JF</given-names>
</name>
</person-group>. <article-title>The genetics of adiposity</article-title>. <source>Curr Opin Genet Dev</source>. (<year>2018</year>) <volume>50</volume>:<fpage>86</fpage>&#x2013;<lpage>95</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.gde.2018.02.009</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liqing</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Maddison</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Zebrafish as a model for obesity and diabetes</article-title>. <source>Front Cell Dev Biol</source>. (<year>2018</year>) <volume>6</volume>:<elocation-id>91</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2018.00091</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nam</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>JY</given-names>
</name>
<etal/>
</person-group>. <article-title>Ethyl gallate dual-targeting PTPN6 and PPAR&#x3b3; shows anti-diabetic and anti-obese effects</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<fpage>p.5020</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23095020</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nibedita</surname> <given-names>N</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Simple techniques to study multifaceted diabesity in the fly model</article-title>. <source>Toxicol Mech Methods</source>. (<year>2019</year>) <volume>29</volume>:<page-range>549&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15376516.2019.1634171</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brenner</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>The genetics of Caenorhabditis elegans</article-title>. <source>Genetics</source>. (<year>1974</year>) <volume>77</volume>:<fpage>71</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/genetics/77.1.71</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Balamurugan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Modulation of the host cell mitochondrial proteome by PemKSa toxin protein exposure</article-title>. <source>Microbial pathogenesis</source>. (<year>2020</year>) <volume>140</volume>:<fpage>103963</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2020.103963</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solis Gregory</surname> <given-names>M</given-names>
</name>
<name>
<surname>Petrascheck</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Measuring Caenorhabditis elegans life span in 96 well microtiter plates</article-title>. <source>JoVE (Journal Visualized Experiments)</source>. (<year>2011</year>) <volume>49</volume>:<fpage>e2496</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/2496</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durai</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vigneshwari</surname> <given-names>L</given-names>
</name>
<name>
<surname>Balamurugan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Caenorhabditis elegans-based in <italic>vivo</italic> screening of bioactives from marine sponge-associated bacteria against Vibrio alginolyticus</article-title>. <source>J Appl Microbiol</source>. (<year>2013</year>) <volume>115</volume>:<page-range>1329&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jam.12335</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rollins Jarod</surname> <given-names>A</given-names>
</name>
<name>
<surname>Howard</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Dobbins</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Washburn</surname> <given-names>EH</given-names>
</name>
<name>
<surname>Rogers</surname> <given-names>AN</given-names>
</name>
</person-group>. <article-title>Assessing health span in Caenorhabditis elegans: lessons from short-lived mutants</article-title>. <source>Journals Gerontology Ser A: Biomed Sci Med Sci</source>. (<year>2017</year>) <volume>72</volume>:<page-range>473&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/gerona/glw248</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angstman</surname> <given-names>NB</given-names>
</name>
<name>
<surname>Kiessling</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Frank</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Schmitz</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>High interindividual variability in dose-dependent reduction in speed of movement after exposing C. elegans to shock waves</article-title>. <source>Front Behav Neurosci</source>. (<year>2015</year>) <volume>9</volume>:<elocation-id>12</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnbeh.2015.00012</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwanir S.</surname>
</name>
<name>
<surname>Tramm</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nagy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ish</surname> <given-names>D</given-names>
</name>
<name>
<surname>Biron</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The microarchitecture of C. elegans behavior during lethargus: homeostatic bout dynamics, a typical body posture, and regulation by a central neuron</article-title>. <source>sleep</source>. (<year>2013</year>) <volume>36</volume>:<page-range>385&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.5665/sleep.2456</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howard</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Mir</surname> <given-names>D</given-names>
</name>
<name>
<surname>Snow</surname> <given-names>S</given-names>
</name>
<name>
<surname>Horrocks</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sayed</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Anabolic function downstream of TOR controls trade-offs between longevity and reproduction at the level of specific tissues in C. elegans</article-title>. <source>Front Aging</source>. (<year>2021</year>) <volume>2</volume>:<elocation-id>725068</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fragi.2021.725068</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mir</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>M</given-names>
</name>
<name>
<surname>Horrocks</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Rogers</surname> <given-names>AN</given-names>
</name>
</person-group>. <article-title>Roles of progranulin and FRamides in neural versus non-neural tissues on dietary restriction-related longevity and proteostasis in C. elegans</article-title>. <source>bioRxiv</source>. (<year>2024</year>), <page-range>2024&#x2013;02</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/2024.02.06.579250</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escorcia</surname> <given-names>W</given-names>
</name>
<name>
<surname>Ruter</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Nhan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Curran</surname> <given-names>SP</given-names>
</name>
</person-group>. <article-title>Quantification of lipid abundance and evaluation of lipid distribution in Caenorhabditis elegans by nile red and oil red O staining</article-title>. <source>JoVE (Journal Visualized Experiments)</source>. (<year>2018</year>) <volume>133)</volume>:<fpage>p.e2.5735</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/57352</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huimin</surname> <given-names>P</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Gan</surname> <given-names>Lu</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of fat accumulation by hesperidin in Caenorhabditis elegans</article-title>. <source>J Agric Food Chem</source>. (<year>2016</year>) <volume>64</volume>:<page-range>5207&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.jafc.6b02183</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gnanasekaran</surname> <given-names>J</given-names>
</name>
<name>
<surname>Durai</surname> <given-names>S</given-names>
</name>
<name>
<surname>Prithika</surname> <given-names>U</given-names>
</name>
<name>
<surname>Marudhupandiyan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dasauni</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kundu</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of DAF-21protein in Caenorhabditis elegans immunity against Proteus mirabilis infection</article-title>. <source>J Proteomics</source>. (<year>2016</year>) <volume>145</volume>:<fpage>81</fpage>&#x2013;<lpage>90</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jprot.2016.03.047</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sivasamy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vigneshwari</surname> <given-names>L</given-names>
</name>
<name>
<surname>Valliammai</surname> <given-names>A</given-names>
</name>
<name>
<surname>Balamurugan</surname> <given-names>K</given-names>
</name>
<name>
<surname>Pandian</surname> <given-names>SK</given-names>
</name>
</person-group>. <article-title>L-Ascorbyl 2, 6-dipalmitate inhibits biofilm formation and virulence in methicillin-resistant Staphylococcus aureus and prevents triacylglyceride accumulation in Caenorhabditis elegans</article-title>. <source>RSC Adv</source>. (<year>2017</year>) <volume>7</volume>:<page-range>23392&#x2013;406</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/C7RA02934A</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basak</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Development of a rapid and inexpensive plasma glucose estimation by two-point kinetic method based on glucose oxidase-peroxidase enzymes</article-title>. <source>Indian J Clin Biochem</source>. (<year>2007</year>) <volume>22</volume>:<page-range>156&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/BF02912902</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullivan David</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kruijswijk</surname> <given-names>Z</given-names>
</name>
<name>
<surname>West</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Kohlmeier</surname> <given-names>M</given-names>
</name>
<name>
<surname>Katan</surname> <given-names>MB</given-names>
</name>
</person-group>. <article-title>Determination of serum triglycerides by an accurate enzymatic method not affected by free glycerol</article-title>. <source>Clin Chem</source>. (<year>1985</year>) <volume>31(7)</volume>:<page-range>1227&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/clinchem/31.7.1227</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vitali</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liebisch</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kurzchalia</surname> <given-names>TV</given-names>
</name>
<name>
<surname>Shevchenko</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schwudke</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics* s*</article-title>. <source>J Lipid Res 49 no</source>. (<year>2008</year>) <volume>5</volume>:<page-range>1137&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1194/jlr.D700041-JLR200</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Touchstone Joseph</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Thin-layer chromatographic procedures for lipid separation</article-title>. <source>J Chromatogr B: Biomed Sci Appl</source>. (<year>1995</year>) <volume>671</volume>:<page-range>169&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0378-4347(95)00232-8</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyuseok</surname> <given-names>Im</given-names>
</name>
<name>
<surname>Mareninov</surname> <given-names>S</given-names>
</name>
<name>
<surname>Diaz</surname> <given-names>MFP</given-names>
</name>
<name>
<surname>Yong</surname> <given-names>WH</given-names>
</name>
</person-group>. <article-title>An introduction to performing immunofluorescence staining</article-title>. <source>Biobanking: Methods Protoc</source>. (<year>2019</year>), <fpage>299</fpage>&#x2013;<lpage>311</lpage>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/dc12-0746</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Balamurugan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>A proteomic analysis of Caenorhabditis elegans mitochondria during bacterial infection</article-title>. <source>Mitochondrion</source>. (<year>2019</year>) <volume>48</volume>:<fpage>37</fpage>&#x2013;<lpage>50</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mito.2019.03.002</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boopathi</surname> <given-names>B</given-names>
</name>
<name>
<surname>VenkataKrishna</surname> <given-names>LM</given-names>
</name>
<name>
<surname>JebaMercy</surname> <given-names>TVG</given-names>
</name>
<name>
<surname>Balamurugan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Salmonella enterica Serovar Typhi exposure elicits deliberate physiological alterations and triggers the involvement of ubiquitin mediated proteolysis pathway in Caenorhabditis elegans</article-title>. <source>Int J Biol macromolecules</source>. (<year>2020</year>) <volume>149</volume>:<page-range>215&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.01.225</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murugesan</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Bhaskar</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Venkateswaran</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ravichandiran</surname> <given-names>V</given-names>
</name>
<name>
<surname>Balamurugan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Proteomic analysis of Caenorhabditis elegans wound model reveals novel molecular players involved in repair</article-title>. <source>J Proteomics</source>. (<year>2021</year>) <volume>240</volume>:<fpage>104222</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jprot.2021.104222</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zulfiqar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bhaskar</surname> <given-names>SB</given-names>
</name>
</person-group>. <article-title>Basic statistical tools in research and data analysis</article-title>. <source>Indian J anaesthesia</source>. (<year>2016</year>) <volume>60</volume>:<page-range>662&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/0019-5049.190623</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Greenway</surname> <given-names>FL</given-names>
</name>
</person-group>. <article-title>Caenorhabditis elegans as a model for obesity research</article-title>. <source>Int J Obes</source>. (<year>2012</year>) <volume>36</volume>:<page-range>186&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ijo.2011.93</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chunxiu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of Momordica saponin extract on alleviating fat accumulation in Caenorhabditis elegans</article-title>. <source>Food Funct</source>. (<year>2019</year>) <volume>10</volume>:<page-range>3237&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/C9FO00254E</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juan</surname> <given-names>B</given-names>
</name>
<name>
<surname>Farias-Pereira</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Park</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>K-H</given-names>
</name>
</person-group>. <article-title>C. elegans ACAT regulates lipolysis and its related lifespan in fasting through modulation of the genes in lipolysis and insulin/IGF-1 signaling</article-title>. <source>BioFactors</source>. (<year>2020</year>) <volume>46</volume>:<page-range>754&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/biof.1666</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malabika</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mitra</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bult-Ito</surname> <given-names>A</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>BE</given-names>
</name>
<name>
<surname>Vayndorf</surname> <given-names>EM</given-names>
</name>
</person-group>. <article-title>Behavioral phenotyping and pathological indicators of Parkinson's disease in C. elegans models</article-title>. <source>Front Genet</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>77</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fgene.2017.00077</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell Aaron</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gastaldi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bobbioni-Harsch</surname> <given-names>E</given-names>
</name>
<name>
<surname>Arboit</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gobelet</surname> <given-names>C</given-names>
</name>
<name>
<surname>D&#xe9;riaz</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids</article-title>? <source>FEBS Lett</source>. (<year>2003</year>) <volume>1-3</volume>:<page-range>104&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0014-5793(03)00875-5</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimsrud Paul</surname> <given-names>A</given-names>
</name>
<name>
<surname>Picklo</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Bernlohr</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal</article-title>. <source>Mol Cell Proteomics 6 no</source>. (<year>2007</year>) <volume>4</volume>:<page-range>624&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/mcp.M600120-MCP200</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anju</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kukreti</surname> <given-names>R</given-names>
</name>
<name>
<surname>Saso</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kukreti.</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes</article-title>. <source>Molecules</source>. (<year>2022</year>) <volume>27</volume>:<fpage>950</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27030950</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stuart Barbara</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Infrared spectroscopy of biological applications</article-title>. <source>Encyclopedia analytical chemistry: applications Theory instrumentation</source>. (<year>2006</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1002/9780470027318.a0208</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akkas</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Severcan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yilmaz</surname> <given-names>O</given-names>
</name>
<name>
<surname>Severcan</surname> <given-names>FER&#x130;. D. E</given-names>
</name>
</person-group>. <article-title>Effects of lipoic acid supplementation on rat brain tissue: An FTIR spectroscopic and neural network study</article-title>. <source>Food Chem 105 no</source>. (<year>2007</year>) <volume>3</volume>:<page-range>1281&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.foodchem.2007.03.015</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anne-Marie</surname> <given-names>M</given-names>
</name>
<name>
<surname>Perromat</surname> <given-names>A</given-names>
</name>
<name>
<surname>D&#xe9;l&#xe9;ris</surname> <given-names>G&#xe9;rard</given-names>
</name>
</person-group>. <article-title>Pharmacologic application of Fourier transform IR spectroscopy: in <italic>vivo</italic> toxicity of carbon tetrachloride on rat liver</article-title>. <source>Biopolymers: Original Res Biomolecules</source>. (<year>2000</year>) <volume>57</volume>:<page-range>160&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/(SICI)1097-0282(2000)57:3&lt;160::AID-BIP4&gt;3.0.CO;2-1</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neslihan</surname> <given-names>T</given-names>
</name>
<name>
<surname>Severcan</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Competitive effect of vitamin D2 and Ca2+ on phospholipid model membranes: an FTIR study</article-title>. <source>Chem Phys Lipids</source>. (<year>2003</year>) <volume>123</volume>:<page-range>165&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0009-3084(02)00194-9</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramasamy</surname> <given-names>M</given-names>
</name>
<name>
<surname>Baraga</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Rava</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Dasari</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Fitzmaurice</surname> <given-names>M</given-names>
</name>
<name>
<surname>Feld</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Biochemical analysis and mapping of atherosclerotic human artery using FT-IR microspectroscopy</article-title>. <source>Atherosclerosis</source>. (<year>1993</year>) <volume>103</volume>:<page-range>181&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0021-9150(93)90261-R</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haris Parvez</surname> <given-names>I</given-names>
</name>
<name>
<surname>Severcan</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>FTIR spectroscopic characterization of protein structure in aqueous and non-aqueous media</article-title>. <source>J Mol Catalysis B: Enzymatic</source>. (<year>1999</year>) <volume>7</volume>:<page-range>207&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1381-1177(99)00030-2</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cinzia</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ferrali</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ciccoli</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sugherini</surname> <given-names>L</given-names>
</name>
<name>
<surname>Magnani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Comporti</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Iron release, membrane protein oxidation and erythrocyte ageing</article-title>. <source>FEBS Lett</source>. (<year>1995</year>) <volume>362(2)</volume>:<page-range>165&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0014-5793(95)00235-2</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonino</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ami</surname> <given-names>D</given-names>
</name>
<name>
<surname>Brocca</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lotti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Doglia</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>Secondary structure, conformational stability and glycosylation of a recombinant Candida rugosa lipase studied by Fourier-transform infrared spectroscopy</article-title>. <source>Biochem J</source>. (<year>2005</year>) <volume>385</volume>:<page-range>511&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20041296</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolkers Willem</surname> <given-names>F</given-names>
</name>
<name>
<surname>Oliver</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Tablin</surname> <given-names>F</given-names>
</name>
<name>
<surname>Crowe</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>A Fourier-transform infrared spectroscopy study of sugar glasses</article-title>. <source>Carbohydr Res</source>. (<year>2004</year>) <volume>339</volume>:<page-range>1077&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.carres.2004.01.016</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nathan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Benning</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Phoenix</surname> <given-names>VR</given-names>
</name>
<name>
<surname>Ferris</surname> <given-names>FG</given-names>
</name>
</person-group>. <article-title>Characterization of metal&#x2013; cyanobacteria sorption reactions: a combined macroscopic and infrared spectroscopic investigation</article-title>. <source>Environ Sci Technol</source>. (<year>2004</year>) <volume>38</volume>:<page-range>775&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/es0346680</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrer Christina</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sodi</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Reginato</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>O-GlcNAcylation in cancer biology: linking metabolism and signaling</article-title>. <source>J Mol Biol 428 no</source>. (<year>2016</year>) <volume>16</volume>:<page-range>3282&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jmb.2016.05.028</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spauwen Peggy</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>K&#xf6;hler</surname> <given-names>S</given-names>
</name>
<name>
<surname>Verhey</surname> <given-names>FRJ</given-names>
</name>
<name>
<surname>Stehouwer</surname> <given-names>CDA</given-names>
</name>
<name>
<surname>Boxtel</surname> <given-names>MPJv</given-names>
</name>
</person-group>. <article-title>Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study</article-title>. <source>Diabetes Care</source>. (<year>2013</year>) <volume>36</volume>:<page-range>1554&#x2013;61</page-range>.</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuligenga Richard</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dugravot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tab&#xe1;k</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Elbaz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Brunner</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Kivim&#xe4;ki</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a <italic>post-hoc</italic> analysis of the Whitehall II cohort study</article-title>. <source>Lancet Diabetes Endocrinol</source>. (<year>2014</year>) <volume>2</volume>:<page-range>228&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S2213-8587(13)70192-X</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Steculorum</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Br&#xfc;ning</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Neuronal control of peripheral insulin sensitivity and glucose metabolism</article-title>. <source>Nat Commun 8 no</source>. (<year>2017</year>) <volume>1</volume>:<fpage>15259</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms15259</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeinab</surname> <given-names>M</given-names>
</name>
<name>
<surname>Neapetung</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pacholko</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kiir</surname> <given-names>TAB</given-names>
</name>
<name>
<surname>Yamamoto</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bekar</surname> <given-names>LK</given-names>
</name>
</person-group>. <article-title>Hyperglycemia induces RAGE-dependent hippocampal spatial memory impairments</article-title>. <source>Physiol Behav</source>. (<year>2021</year>) <volume>229</volume>:<fpage>113287</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.physbeh.2020.113287</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrea</surname> <given-names>Gonz&#xe1;lez</given-names>
</name>
<name>
<surname>Calf&#xed;o</surname> <given-names>C</given-names>
</name>
<name>
<surname>Churruca</surname> <given-names>M</given-names>
</name>
<name>
<surname>Maccioni</surname> <given-names>RB</given-names>
</name>
</person-group>. <article-title>Glucose metabolism and AD: Evidence for a potential diabetes type 3</article-title>. <source>Alzheimer's Res Ther</source>. (<year>2022</year>) <volume>14</volume>:<fpage>56</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13195-022-00996-8</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahoney Timothy</surname> <given-names>R</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nonet</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay</article-title>. <source>Nat Protoc</source>. (<year>2006</year>) <volume>4</volume>:<page-range>1772&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nprot.2006.281</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsalik Ephraim</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hobert</surname> <given-names>O</given-names>
</name>
</person-group>. <article-title>Functional mapping of neurons that control locomotory behavior in Caenorhabditis elegans</article-title>. <source>J Neurobiol 56 no</source>. (<year>2003</year>) <volume>2</volume>:<page-range>178&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/neu.10245</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glenn Charles</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>DK</given-names>
</name>
<name>
<surname>David</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cooke</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Gami</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Iser</surname> <given-names>WB</given-names>
</name>
<etal/>
</person-group>. <article-title>Behavioral deficits during early stages of aging in Caenorhabditis elegans result from locomotory deficits possibly linked to muscle frailty</article-title>. <source>Journals Gerontology Ser A: Biol Sci Med Sci</source>. (<year>2004</year>) <volume>12</volume>:<page-range>1251&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/gerona/59.12.1251</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokumitsu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kitagawa</surname> <given-names>I</given-names>
</name>
<name>
<surname>Shingai</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Neurons regulating the duration of forward locomotion in Caenorhabditis elegans</article-title>. <source>Neurosci Res</source>. (<year>2004</year>) <volume>50</volume>:<page-range>103&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neures.2004.06.005</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nahabedian John</surname> <given-names>F</given-names>
</name>
<name>
<surname>Qadota</surname> <given-names>H</given-names>
</name>
<name>
<surname>Stirman</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Benian</surname> <given-names>GM</given-names>
</name>
</person-group>. <article-title>Bending amplitude&#x2013;A new quantitative assay of C. elegans locomotion: Identification of phenotypes for mutants in genes encoding muscle focal adhesion components</article-title>. <source>Methods</source>. (<year>2012</year>) <volume>1</volume>:<fpage>95</fpage>&#x2013;<lpage>102</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ymeth.2011.11.005</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ankita</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Yen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tissenbaum</surname> <given-names>HA</given-names>
</name>
</person-group>. <article-title>Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2015</year>) <volume>3</volume>:<page-range>E277&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1412192112</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andr&#xe9;s</surname> <given-names>V-G</given-names>
</name>
<name>
<surname>Topper</surname> <given-names>S</given-names>
</name>
<name>
<surname>Young</surname> <given-names>L</given-names>
</name>
<name>
<surname>Crisp</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kressin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Elbel</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Caenorhabditis elegans selects distinct crawling and swimming gaits via dopamine and serotonin</article-title>. <source>Proc Natl Acad Sci</source>. (<year>2011</year>) <volume>42</volume>:<page-range>17504&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1108673108</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawin Elizabeth</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ranganathan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Horvitz</surname> <given-names>XXXHR</given-names>
</name>
</person-group>. <article-title>C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway</article-title>. <source>Neuron</source>. (<year>2000</year>) <volume>3</volume>:<page-range>619&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0896-6273(00)81199-X</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young-Ki</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>S-K</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>E-Y</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>P-Y</given-names>
</name>
<name>
<surname>Shim</surname> <given-names>Y-H</given-names>
</name>
</person-group>. <article-title>C. elegans: an invaluable model organism for the proteomics studies of the cholesterol-mediated signaling pathway</article-title>. <source>Expert Rev Proteomics</source>. (<year>2006</year>) <volume>3</volume>:<page-range>439&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1586/14789450.3.4.439</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avery</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Bailey</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>The effects of the Maillard reaction on the physical properties and cell interactions of collagen</article-title>. <source>Pathologie Biologie 54 no</source>. (<year>2006</year>) <volume>7</volume>:<page-range>387&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.patbio.2006.07.005</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiina</surname> <given-names>Pet&#xe4;ist&#xf6;</given-names>
</name>
<name>
<surname>Vicente</surname> <given-names>D</given-names>
</name>
<name>
<surname>M&#xe4;kel&#xe4;</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Finnil&#xe4;</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Miinalainen</surname> <given-names>I</given-names>
</name>
<name>
<surname>Koivunen</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Lack of collagen XVIII leads to lipodystrophy and perturbs hepatic glucose and lipid homeostasis</article-title>. <source>J Physiol</source>. (<year>2020</year>) <volume>16</volume>:<page-range>3373&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/JP279559</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nava</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Desevin</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mackenzie</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lord</surname> <given-names>A</given-names>
</name>
<name>
<surname>Grishok</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kandror</surname> <given-names>KV</given-names>
</name>
</person-group>. <article-title>ATGL-1 mediates the effect of dietary restriction and the insulin/IGF-1 signaling pathway on longevity in C. elegans</article-title>. <source>Mol Metab</source>. (<year>2019</year>) <volume>27</volume>:<fpage>75</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molmet.2019.07.001</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herdenberg</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mutie</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Billing</surname> <given-names>O</given-names>
</name>
<name>
<surname>Abdullah</surname> <given-names>A</given-names>
</name>
<name>
<surname>Strawbridge</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Dahlman</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes</article-title>. <source>Commun Biol</source>. (<year>2021</year>) <volume>4</volume>:<fpage>p.90</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42003-020-01613-w</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin-Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>W</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Histone H3K4me3 modification is a transgenerational epigenetic signal for lipid metabolism in Caenorhabditis elegans</article-title>. <source>Nat Commun</source>. (<year>2022</year>) <volume>1</volume>:<fpage>768</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-022-28469-4.</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yahui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Trabucco</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Oxidative stress, mitochondrial dysfunction and the mitochondria theory of aging</article-title>. <source>Aging</source>. (<year>2014</year>) <volume>39</volume>:<fpage>86</fpage>&#x2013;<lpage>107</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000358901</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson Adiv</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stolzing</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The role of lipid metabolism in aging, lifespan regulation, and age-related disease</article-title>. <source>Aging Cell</source>. (<year>2019</year>) <volume>18</volume>:<elocation-id>e13048</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.13048</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Soudabeh</surname> <given-names>I</given-names>
</name>
<name>
<surname>St&#xfc;rzenbaum</surname> <given-names>SR</given-names>
</name>
</person-group>. <article-title>Animal models for the study of human disease: chapter 12</article-title>. In: <source>Invertebrates in obesity research: A worm&#x2019;s perspective</source>. <publisher-loc>British library, Elsevier books, UK</publisher-loc>: <publisher-name>Elsevier Inc</publisher-name> (<year>2013</year>).</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sohal</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Brunk</surname> <given-names>UT</given-names>
</name>
</person-group>. <article-title>Lipofuscin as an indicator of oxidative stress and aging</article-title>. <source>Adv Exp Med Biol</source>. (<year>1989</year>) <volume>266</volume>:<fpage>17</fpage>&#x2013;<lpage>26</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4899-5339-1_2</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cloke George</surname> <given-names>V</given-names>
</name>
<name>
<surname>Jacobson</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>The autofluorescent lipofuscin granules in the intestinal cells of Caenorhabditis elegans are secondary lysosomes</article-title>. <source>Mech Ageing Dev</source>. (<year>1986</year>) <volume>1</volume>:<fpage>79</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0047-6374(86)90068-0.</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lital</surname> <given-names>A-F</given-names>
</name>
<name>
<surname>Rosenzweig</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Redox balance in type 2 diabetes: therapeutic potential and the challenge of antioxidant-based therapy</article-title>. <source>Antioxidants</source>. (<year>2023</year>) <volume>12</volume>:<fpage>994</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox12050994</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>An</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Application of caenorhabditis elegans in lipid metabolism research</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>2</volume>:<fpage>1173</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24021173</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wenyan</surname> <given-names>Lu</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of choline deficiency and supplementation on lipid droplet accumulation in bovine primary liver cells in <italic>vitro</italic>
</article-title>. <source>J Dairy Sci</source>. (<year>2023</year>) <volume>12</volume>:<page-range>9868&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3168/jds.2023-23452</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez Bryan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Medina</surname> <given-names>RMNu&#xf1;ez</given-names>
</name>
<name>
<surname>Mondal</surname> <given-names>P</given-names>
</name>
<name>
<surname>Harrison</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Lone</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>An alternatively spliced, non-signaling insulin receptor modulates insulin sensitivity via insulin peptide sequestration in C. elegans</article-title>. <source>Elife</source>. (<year>2020</year>) <volume>9</volume>:<fpage>e49917</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.49917</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rulifson Eric</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Nusse</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes</article-title>. <source>Science</source>. (<year>2002</year>) <volume>296</volume>:<page-range>1118&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1070058</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gennaro</surname> <given-names>P</given-names>
</name>
<name>
<surname>Polychronis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>H</given-names>
</name>
<name>
<surname>Giordano</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ferrara</surname> <given-names>N</given-names>
</name>
<name>
<surname>Niccolini</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Diabetes mellitus and Parkinson disease</article-title>. <source>Neurology</source>. (<year>2018</year>) <volume>90</volume>:<page-range>e1654&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1212/WNL.000000000000547</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdallah</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kandel</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gautam</surname> <given-names>J</given-names>
</name>
<name>
<surname>Alaref</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jahan</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Diabetes mellitus and Parkinson's disease: shared pathophysiological links and possible therapeutic implications</article-title>. <source>Cureus</source>. (<year>2020</year>) <volume>12</volume>:<elocation-id>e9853</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7759/cureus.9853</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eva</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hansen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rugbjerg</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wermuth</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ritz</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Diabetes and the risk of developing Parkinson&#x2019;s disease in Denmark</article-title>. <source>Diabetes Care</source>. (<year>2011</year>) <volume>34</volume>:<page-range>1102&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/dc10-1333</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muhasin</surname> <given-names>K</given-names>
</name>
<name>
<surname>Gummadi</surname> <given-names>SN</given-names>
</name>
</person-group>. <article-title>Regulation and functions of membrane lipids: Insights from Caenorhabditis elegans</article-title>. <source>BBA Adv</source>. (<year>2022</year>) <volume>2</volume>:<fpage>100043</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadva.2022.100043</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Intestinal fatty acid binding protein: A rising therapeutic target in lipid metabolism</article-title>. <source>Prog Lipid Res</source>. (<year>2022</year>) <volume>87</volume>:<fpage>101178</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.plipres.2022.101178</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konstantinos</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mari</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ploumi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Princz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Filippidis</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tavernarakis</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Age-dependent nuclear lipid droplet deposition is a cellular hallmark of aging in Caenorhabditis elegans</article-title>. <source>Aging Cell</source>. (<year>2023</year>) <volume>22</volume>:<fpage>e13788</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/acel.13788</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garc&#xed;a-Vega</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez-Juanatey</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Eiras</surname> <given-names>S</given-names>
</name>
</person-group>
<article-title>Diabesity in elderly cardiovascular disease patients: mechanisms and regulators</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<fpage>7886</fpage>.</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marta</surname> <given-names>K</given-names>
</name>
<name>
<surname>Walendzik</surname> <given-names>K</given-names>
</name>
<name>
<surname>Bukowska</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kur-Piotrowska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Machcinska</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gimble</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Cutaneous wound healing in aged, high fat diet-induced obese female or male C57BL/6 mice</article-title>. <source>Aging (Albany NY)</source>. (<year>2020</year>) <volume>8</volume>:<fpage>7066</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/aging.103064</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bays Harold</surname> <given-names>E</given-names>
</name>
<name>
<surname>Chapman</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Grandy</surname> <given-names>S</given-names>
</name>
<collab>SHIELD Investigators&#x2019; Group</collab>
</person-group>. <article-title>The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys</article-title>. <source>Int J Clin Pract</source>. (<year>2007</year>) <volume>61</volume>:<page-range>737&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ijcp.2007.61.issue-5</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>RBAM</given-names>
</name>
<name>
<surname>Barden</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mori</surname> <given-names>T</given-names>
</name>
<name>
<surname>Beilin</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Advanced glycation end-products: a review</article-title>. <source>Diabetologia</source>. (<year>2001</year>) <volume>44</volume>:<page-range>129&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s001250051591</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borysivna</surname> <given-names>BL</given-names>
</name>
</person-group>. <article-title>Diabetes and collagen: interrelations</article-title>. <source>Avicenna J Med Biochem</source>. (<year>2019</year>) <volume>7</volume>:<fpage>64</fpage>&#x2013;<lpage>71</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.34172/ajmb.2019.12</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masaharu</surname> <given-names>U</given-names>
</name>
<name>
<surname>Tani</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nono</surname> <given-names>M</given-names>
</name>
<name>
<surname>Okabe</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kishimoto</surname> <given-names>S</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Neuronal DAF-16-to-intestinal DAF-16 communication underlies organismal lifespan extension in C. elegans</article-title>. <source>Iscience</source>. (<year>2021</year>) <volume>24</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.isci.2021.102706</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renne Mike</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hariri</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Lipid droplet-organelle contact sites as hubs for fatty acid metabolism, trafficking, and metabolic channeling</article-title>. <source>Front Cell Dev Biol</source>. (<year>2021</year>) <volume>9</volume>:<elocation-id>726261</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcell.2021.726261</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>